Inventor · disambiguated record
Anton Pekcec
Also filed as: PEKCEC ANTON
7 granted patents·4 pending applications·6 citations·filing 2017–2024
72Inventor score
Files withBOEHRINGER INGELHEIM INT11
Top patents by PatentIndex Score
11 records- 0185US9884854B2N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Feb 6, 2018·6 cites·4 claims
- 0274US12421218B2Substituted pyrazine-carboxamide derivativesBOEHRINGER INGELHEIM INT·Filed 2024·Granted Sep 23, 2025·0 cites·14 claims
- 0367US2024174652A1Novel dioxane derivativesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0467US2024182453A1Novel substituted pyrazine-carboxamide derivativesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0559US2025333459A1Recombinant expression of myeloid-derived growth factorBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0656US10710984B2N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jul 14, 2020·0 cites·8 claims
- 0755US10787432B2N-[(pyridyloxy)propanyl]benzamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Sep 29, 2020·0 cites·4 claims
- 0849US10738031B2N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activityBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 11, 2020·0 cites·9 claims
- 0949US10604511B2N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activityBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 31, 2020·0 cites·8 claims
- 1043US2023059560A1Myeloid-derived growth factor for use in treating or preventing fibrosis, hypertrophy or heart failureBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1141US10392369B2N-[(pyrimidinyloxy)propanyl]benzamidesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 27, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Anton Pekcec files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →